Inflammation in heart failure: pathophysiology and therapeutic strategiesJacinthe Boulet, Michel White, Vikas S. Sridhar et al.|Inflammation Research|2024Cited by 129
Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney diseaseHongyan Liu, David Z.I. Cherney, Vikas S. Sridhar et al.|Metabolism|2021Cited by 80
Cancer Screening in Solid Organ Transplant Recipients: A Focus on Screening Liver, Lung, and Kidney Recipients for Cancers Related to the Transplanted OrganAtit Dharia, Abhijat Kitchlu, Jacinthe Boulet et al.|Transplantation|2021Cited by 32
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetesVikas S. Sridhar, David Z.I. Cherney, Christine P. Limonte et al.|Diabetologia|2023Cited by 25
Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protectionVikas S. Sridhar, David Z.I. Cherney, Lisa Dubrofsky et al.|Brazilian Journal of Nephrology|2020Cited by 15